About this trial
The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Males and females, age 18 or older
Can provide an Informed Consent in English.
Absence of a single posterior tooth in mandible or maxilla with presence of natural neighboring teeth (except for second molar which only requires presence of first molar)
Presence of antagonist teeth
Disqualifiers
· Unavailability to attend the follow-up visits.
A systemic contraindication for oral surgical procedures; ASA III or IV.
Pregnancy or nursing on screening or before the surgical procedure.
Diseases that could alter healing or bone metabolism (uncontrolled diabetes, diagnostic osteoporosis, etc.),
Trial design
Parallel
Treatments tested in this trial
Nobel N1 implant
DeviceA Nobel N1 implant will be placed and restored with a On 1 base
Treatment groups
Trial outcomes
Primary outcomes
Implant survival
Implant survival will be measured if it is not failed and still present at time points
Misch implant success criteria
Implant success will be measured according to Misch et al.
Secondary outcomes
Marginal bone loss
Marginal bone loss from the platform of the implant will be measured on Peri-apical X-rays and bitewings
Probing depth
Probing depths will be measured at 6 surfaces
Presence of sulcular suppuration on gentle probing
Presence or absence of suppuration will be evaluated upon gentle probing at 6 surfaces around the implant
Presence of sulcular bleeding on gentle probing
Presence or absence of bleeding will be evaluated upon gentle probing at 6 surfaces around the implant
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Louisiana State University Health Sciences Center in New Orleans
Lead sponsor
Envista (Nobel Biocare)
Collaborator